The DiaCoVAb study in South Italy: immune response to Sars-CoV-2 vaccination in dialysis patients

The DiaCoVAb study in South Italy: immune response to Sars-CoV-2 vaccination in dialysis patients

Introduction. Since the pandemic of Coronavirus Disease 2019 (COVID-19) started from December 2019, remarkable numbers of infections and deaths associated with COVID-19 have been recorded worldwide. End-Stage Renal Disease (ESRD) patients on dialysis are particularly at high risk of infections due t...

Full description

Bibliographic Details
Main Authors: Alessandra Fucci, Simona Giacobbe, Ilaria Guerriero, Yoko Suzumoto, Egildo Luca D'Andrea, Marianna Scrima, Maria Luisa Nolli, Anna Iervolino, Luigi Amedeo Chiuchiolo, Ermanno Salvatore, Roberta Renzulli, Ludovico La Peccerella, Giuseppe Marra, Marco Liuzzi, Domenico Santoro, Enrico Zulli, Romolo Gentile, Gennaro Clemente, Giovambattista Capasso
Format: Article
Language:English
Published: Karger Publishers 2022-03-01
Series:Kidney & Blood Pressure Research
Online Access:https://www.karger.com/Article/FullText/524034

Internet

https://www.karger.com/Article/FullText/524034

Similar Items